Standardization of assay methods reduces variability of total PSA measurements: An Irish study

BJU International

Volumn 110, Issue 5, 2012, Pages 644-650

  Forde, James C ^a   Marignol, Laure ^a   Blake, Ophelia ^a   McDermott, Ted ^a   Grainger, Ronald ^a   Crowley, Vivien E ^a   Lynch, Thomas H ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

assay; Ireland; prostate cancer; total prostate specific antigen; variability

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; HOSPITAL; HOSPITAL DEPARTMENT; HUMAN; IMMUNOASSAY; IRELAND; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; STANDARDIZATION;

CANCER CARE FACILITIES; COHORT STUDIES; EARLY DETECTION OF CANCER; HUMANS; IMMUNOASSAY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY;

EID: 84865335131     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10923.x     Document Type: Article

References (30)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P,. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92 (Pubitemid 46359643)
2. NCRI. Trends in Irish Cancer Incidence 1994-2002, with Projections to 2020. Dublin: National Cancer Registry Ireland, 2006
3. Bono AV,. The global state of prostate cancer: epidemiology and screening in the second millennium. BJU Int 2004; 94 (Suppl. 3): 1-2 (Pubitemid 40052124)
4. Rao AR, Motiwala HG, Karim OM,. The discovery of prostate-specific antigen. BJU Int 2008; 101: 5-10 (Pubitemid 350233553)
5. Hara M, Koyanagi Y, Inoue T, Fukuyama T,. Some physico-chemical characteristics of "-seminoprotein", an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII. Nihon Hoigaku Zasshi 1971; 25: 322-4
6. Wang MC, Valenzuela LA, Murphy GP, Chu TM,. Purification of a human prostate specific antigen. Invest Urol 1979; 17: 159-63 (Pubitemid 10132507)
7. Fitzpatrick JM, Banu E, Oudard S,. Prostate-specific antigen kinetics in localized and advanced prostate cancer. BJU Int 2009; 103: 578-87
8. Polascik TJ, Oesterling JE, Partin AW,. Prostate specific antigen: a decade of discovery-what we have learned and where we are going. J Urol 1999; 162: 293-306 (Pubitemid 29434327)
9. Blanchet J, Brinkmann T,. The Clinical Impact of WHO Standardization of PSA Assays. J Med Biochem 2008; 27: 161-8 (Pubitemid 351777185)
10. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH,. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992; 147: 841-5
11. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156-61
12. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 2004; 350: 2239-46
13. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8
14. Kort SA, Martens F, Vanpoucke H, van Duijnhoven HL, Blankenstein MA,. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation. Clin Chem 2006; 52: 1568-74 (Pubitemid 44148320)
15. Roddam AW, Rimmer J, Nickerson C, Ward AM,. Prostate-specific antigen: bias and molarity of commercial assays for PSA in use in England. Ann Clin Biochem 2006; 43: 35-48 (Pubitemid 43105056)
16. Semjonow A, De Angelis G, Oberpenning F, Schmid HP, Brandt B, Hertle L,. The clinical impact of different assays for prostate specific antigen. BJU Int 2000; 86: 590-7
17. Semjonow A, Oberpenning F, Brandt B, Zechel C, Brandau W, Hertle L,. Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen. Urology 1996; 48: 10-5 (Pubitemid 27004854)
18. Stephan C, Kramer J, Meyer HA, et al. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies. BJU Int 2007; 99: 1427-31 (Pubitemid 47164809)
19. Venkitaraman R, Norman AR, Iqbal J, et al. Clinical implications of introducing a new PSA assay. Int Urol Nephrol 2008; 40: 657-61
20. Link RE, Shariat SF, Nguyen CV, et al. Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening. J Urol 2004; 171: 2234-8 (Pubitemid 38625442)
21. Chan DW, Sokoll LJ,. WHO first international standards for prostate-specific antigen: the beginning of the end for assay discrepancies? Clin Chem 2000; 46: 1291-2
22. Rafferty B, Rigsby P, Rose M, Stamey T, Gaines Das R,. Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10). Clin Chem 2000; 46: 1310-7
23. Stamey TA, Chen Z, Prestigiacomo AF,. Reference material for PSA: the IFCC standardization study. International Federation of Clinical Chemistry. Clin Biochem 1998; 31: 475-81 (Pubitemid 28391887)
24. Stephan C, Bangma C, Vignati G, et al. 20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials-analysis of 1098 patients in four centers. Int J Biol Markers 2009; 24: 65-9
25. Fillee C, Tombal B, Philippe M,. Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access prostate-specific antigen assays. Clin Chem Lab Med 2010; 48: 285-8
26. Drummond FJ, Carsin AE, Sharp L, Comber H,. Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines. Ir J Med Sci 2010; 179: 43-9
27. Drummond FJ, Sharp L, Comber H,. Major inter-laboratory variations in PSA testing practices: results from national surveys in Ireland in 2006 and 2007. Ir J Med Sci 2008; 177: 317-23
28. A Strategy for Cancer Control in Ireland-National Cancer Forum 2006. Department of Health and Children, Ireland. Available at: http://www.dohc.ie/ publications/cancer-control-2006.html?lang=en. Accessed July 2011
29. Blijenberg BG, Storm BN, Kruger AE, Schroder FH,. On the standardization of total prostate-specific antigen: an exercise with two reference preparations. Clin Chem Lab Med 1999; 37: 545-52 (Pubitemid 29304420)
30. Howell AM, Parnham A, Karim O, Kavia R,. Screening for prostate cancer. First, standardise the assay. BMJ 2010; 341: c5813